REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
04/18/2025
Back to search
Official data from USPTO
ANTICALIN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ANTICALIN
ST13
US500000078143412Class
1, 5, 42
Filing
78143412
Registration
3081539
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
48
Latest update
04/19/2025
Trademark type
Word
Nice classes
1, 5, 42
Filing date
07/12/2002
Registration date
04/18/2006
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/05/2016
Last transaction
04/19/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
Drawing code
1
Owner type
16
Owner location
FREISING, US
Examiner
THOMAS,AMY E
Law office
M10
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
PIERIS PHARMACEUTICALS GMBH
PIERIS AG
Pieris Proteolab AG
Representatives
Michael J. Leonard Fox Rothschild LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals used in industry and sciencenamely conjugates of organic and inorganic chemicals with polypeptidesproteinsartificial polypeptides and artificial proteins produced by genetic engineeringnucleic acid molecule encoding these polypeptidesproteins all for scientific and research usebiochemicals and biopharmaceuticalsnamely polypeptidesproteinsartificial polypeptides and artificial proteins produced by genetic engineeringnucleic acid molecule encoding these polypeptidesproteins all for scientific and research usediagnostic preparations for scientific and research use; diagnostic reagents for scientific and research use
Class 5
Pharmaceuticalveterinarysanitary and diagnostic preparationsnamely conjugates of organic and inorganic chemicals with polypeptidesproteinsartificial polypeptidesartificial proteins produced by genetic engineeringnucleic acid molecules encoding these polypeptides and proteinsartificial polypeptides and artificial proteins produced by genetic engineeringnucleic acid molecules encoding such polypeptides and proteins; diagnostic preparations for clinical and medical laboratory use; diagnostic reagents for clinical and medical laboratory use; medical diagnostic reagents
Class 42
Research in science and industrynamely research in the areas of biochemistrydiagnostics and pharmaceuticals; chemical laboratories; laboratory research in the field of life scienceshealthcare and medicinal researchagrochemistryveterinary usesenvironmental technologyfood and flavor industryprotein-chip industry
Publications
History of USPTO decisions and trademark events.
48 publications found
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12/05/2016
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
12/05/2016
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/05/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/05/2016
E89R
TEAS SECTION 8 & 9 RECEIVED
09/24/2016
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
09/14/2016
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/31/2016
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
04/18/2015
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/04/2013
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/29/2012
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/29/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/29/2012
E815
TEAS SECTION 8 & 15 RECEIVED
02/22/2012
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/15/2012
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/16/2010
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/16/2010
R.PR
REGISTERED-PRINCIPAL REGISTER
04/18/2006
PUBO
PUBLISHED FOR OPPOSITION
01/24/2006
NPUB
NOTICE OF PUBLICATION
01/04/2006
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/13/2005
ALIE
ASSIGNED TO LIE
12/09/2005
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/07/2005
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
12/07/2005
ATRQ
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
09/21/2005
ADBS
1(B) BASIS DELETED; NEW BASIS REQUESTED
09/21/2005
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
09/19/2005
IUCN
NOTICE OF ALLOWANCE CANCELLED
08/19/2005
PDCB
PETITION TO DIRECTOR - CHANGE BASIS - RECEIVED
08/19/2005
PAPER RECEIVED
08/19/2005
EX3G
SOU EXTENSION 3 GRANTED
02/16/2005
EXT3
SOU EXTENSION 3 FILED
02/16/2005
PAPER RECEIVED
02/16/2005
EX2G
SOU EXTENSION 2 GRANTED
09/02/2004
EXT2
SOU EXTENSION 2 FILED
08/17/2004
PAPER RECEIVED
08/17/2004
CFIT
CASE FILE IN TICRS
08/17/2004
EX1G
SOU EXTENSION 1 GRANTED
03/02/2004
EXT1
SOU EXTENSION 1 FILED
02/13/2004
PAPER RECEIVED
02/13/2004
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
08/19/2003
PUBO
PUBLISHED FOR OPPOSITION
05/27/2003
NPUB
NOTICE OF PUBLICATION
05/07/2003
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/20/2003
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/03/2003
PAPER RECEIVED
03/03/2003
CNRT
NON-FINAL ACTION MAILED
01/31/2003
DOCK
ASSIGNED TO EXAMINER
01/16/2003
Continuous trademark protection
Get notified about every new filing that threatens ANTICALIN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.